NUDT15 update With the recent Crohn’s Disease update, we have also updated the way our software processes NUDT15 genetic data. Previously, the software assessed reported genotypes for NUDT15 rs116855232. With this update, we now assess drug-gene interactions with NUDT15 based on phenotype (i.e. metabolizer status),...
All TreatGx users now have access to the updated Crohn’s disease treatment algorithm. Crohn’s Disease This comprehensive update incorporates information from AGA 2021[1] and ACG 2018[2] to help clinicians personalize treatment for their patients. A key update to this algorithm is the restructuring of therapy streams to allow...
TreatGx users now have access to the updated treatment algorithm for Chronic Obstructive Pulmonary Disease (COPD) – Acute Exacerbation. As always, this update includes the TreatGx standard of providing personalized dosing based on kidney function, liver function, and drug interactions. This update was based on recent...
TreatGx users now have access to the updated treatment algorithm for Rheumatoid Arthritis. As always, this update includes the TreatGx standard of providing personalized dosing based on kidney function, liver function, and drug interactions. This is based on the 2021 American College of Rheumatology Guideline for...
GenXys recognized for achievements in precision prescribing platform NEW YORK, December 7, 2022 -- CB Insights today named GenXys to its fourth-annual Digital Health 150, showcasing the 150 most promising private digital health companies of 2022. "From reimagining clinical care, to leveraging tech like AR/VR to improve...
